Hikma Pharmaceuticals Plc Total Voting Rights (8029U)
January 03 2013 - 10:55AM
UK Regulatory
TIDMHIK
RNS Number : 8029U
Hikma Pharmaceuticals Plc
03 January 2013
Hikma Pharmaceuticals PLC
Voting Rights and Capital
LONDON, 3 January 2013, Hikma Pharmaceuticals PLC (LSE: HIK)
(NasdaqDubai: HIK) notifies the market that its capital consists of
197,036,507 ordinary shares with voting rights. There are no shares
held in treasury.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest
in, Hikma Pharmaceuticals PLC under the FSA's Disclosure and
Transparency Rules.
- ENDS -
Enquiries
Hikma Pharmaceuticals PLC
Peter Speirs
Company Secretary +44 20 7399 2760
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational
pharmaceutical group focused on developing, manufacturing and
marketing a broad range of both branded and non--branded generic
and in--licensed products. Hikma's operations are conducted through
three businesses: "Branded", "Injectables" and "Generics" based
principally in the Middle East and North Africa ("MENA") region,
where it is a market leader, the United States and Europe. In 2011,
Hikma achieved revenue of $918.0 million and profit attributable to
shareholders of $80.1 million.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVREASFDESSDEFF
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024